Search

Search Results

• 

  Acne exacerbation after tofacitinib treatment for alopecia areata

  Sawsan Alharthi, Mohammed G. Turkmani, Mohammed I. AlJasser

  01-01-2022

  https://doi.org/10.4081/dr.2022.9396

  2682

  PDF: 893

  HTML: 44

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2867

  PDF: 1015

  HTML: 40
• 

  Atopic dermatitis: a brief review of recent advances in its management

  Sultan Daghafak Alenazi

  23-05-2023

  https://doi.org/10.4081/dr.2023.9678

  2530

  PDF: 1454

  HTML: 128

• Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies

  Claudia Paganini, Edoardo Mortato, Lorenzo Tofani, Alfredo Belcastro, Marina Talamonti, Cosimo Di Raimondo, Luca Bianchi, Marco Galluzzo

  04-03-2025

  https://doi.org/10.4081/dr.2025.10193

  1397

  PDF: 621

  HTML: 47

• Targeting JAK/STAT signaling: ruxolitinib cream in the management of concurrent vitiligo and discoid lupus erythematosus

  Andrea Bassi, Vincenzo Piccolo, Grazia Gallippi, Giuseppe Argenziano, Michela Magnano, Carlo Mazzatenta

  11-09-2025

  https://doi.org/10.4081/dr.2025.10458

  457

  PDF: 364

  HTML: 25
• 

  Vitiligo: What’s old, what’s new

  Mariabeatrice Bertolani, Eleonora Rodighiero, Maria Beatrice de Felici del Giudice, Torello Lotti, Claudio Feliciani, Francesca Satolli

  15-09-2021

  https://doi.org/10.4081/dr.2021.9142

  2922

  PDF: 1198

  HTML: 233

• Psoriasiform eruption induced by dupilumab successfully treated with upadacitinib

  Mattia Minghini, Natale Schettini, Lucrezia Pacetti, Chiara Bocchi, Alessandro Borghi

  16-10-2025

  https://doi.org/10.4081/dr.2025.10588

  462

  PDF: 234

  HTML: 4

• Refractory pityriasis rubra pilaris treated with abrocitinib

  Filip Rob

  09-01-2025

  https://doi.org/10.4081/dr.2025.10105

  521

  PDF: 331

  HTML: 27

• Venous thromboembolism in bullous pemphigoid: current evidence from an updated systematic review

  Atheer G. Almutairi, Abeer G. Almutairi, Rahaf R. Almutairi, Asem Shadid, Alhanouf A. Bin Dakhil, Lamia Alakrash

  29-01-2025

  https://doi.org/10.4081/dr.2025.10257

  909

  PDF: 421

  SUPPLEMENTARY MATERIAL: 91

  HTML: 12

• Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

  Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili

  13-03-2025

  https://doi.org/10.4081/dr.2025.10021

  545

  PDF: 370

  HTML: 16

• Effectiveness and safety of topical L-ascorbic acid 15% serum compared to retinol 0.1% serum for skin aging: a double-blind randomized controlled trial study

  Keiko Yolanda Gunardi, Endi Novianto, Triana Agustin, Dewi Friska, Githa Rahmayunitha

  28-05-2026

  https://doi.org/10.4081/dr.2026.10293

  1892

  PDF: 484

• Paradoxical reaction under dupilumab triggered by occasional ketoprofen intake

  Filippo Chersi, Sanja Javor, Rosella Gallo, Elia Sala, Cesare Massone

  28-02-2025

  https://doi.org/10.4081/dr.2025.10214

  1011

  PDF: 765

  HTML: 15

• Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient Use of upadacitinib in pediatric comorbidities

  Edoardo Mortato, Ludovico Maria Rao, Marina Aloi, Arnaldo Cioni, Enrico Matteini, Angela Fico, Sara Lambiase, Ruslana Gaeta Shumak, Luca Bianchi, Elena Campione, Laura Diluvio

  09-01-2026

  https://doi.org/10.4081/dr.2026.10165

  838

  PDF: 542

• Successful treatment of refractory generalized granuloma annulare with abrocitinib

  Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Vittorio Tancredi, Giuseppe Argenziano, Eugenia Veronica Di Brizzi

  23-01-2026

  https://doi.org/10.4081/dr.2026.10296

  506

  PDF: 315
• 

  Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

  Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan

  21-11-2022

  https://doi.org/10.4081/dr.2022.9492

  1832

  PDF: 703

  HTML: 92

• Successful use of upadacitinib for the improvement of vitiligo-like and perifollicular dyspigmentation (salt-and-pepper skin) in systemic sclerosis

  Giovanni Paolino, Matteo Riccardo Di Nicola, Santo Raffaele Mercuri, Valentina Canti

  12-02-2026

  https://doi.org/10.4081/dr.2026.10652

  500

  PDF: 364

• The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

  Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi

  01-07-2025

  https://doi.org/10.4081/dr.2025.10112

  1040

  PDF: 771

  HTML: 42

• Underrepresentation of atopic dermatitis publications in pediatric journals: a bibliometric analysis

  Barak Zlakishvili, Sarah Weissmann, Amir Horev

  12-04-2024

  https://doi.org/10.4081/dr.2024.9932

  748

  PDF: 557

  SUPPLEMENTARY MATERIAL: 176

  HTML: 21

• Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

  Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris

  03-02-2026

  https://doi.org/10.4081/dr.2026.10644

  785

  PDF: 523

• Keratosis lichenoides chronica: a case report with dermatoscopic and ultrasonographic analysis

  Katarzyna Korecka, Monika Bowszyc-Dmochowska, Nina Łabędź, Ryszard Żaba, Aleksandra Dańczak-Pazdrowska, Adriana Polańska

  11-06-2025

  https://doi.org/10.4081/dr.2025.10093

  526

  PDF: 397

  HTML: 53
• 

  The efficacy and safety of fractional erbium yag laser combined with topical amniotic membrane stem cell (AMSC) metabolite product for facial rejuvenation: A controlled, split-face study

  Ni Putu Susari Widianingsih, Trisniartami Setyaningrum, Cita Rosita S. Prakoeswa

  29-03-2019

  https://doi.org/10.4081/dr.2019.8036

  1618

  PDF: 709

• Fast response in facial vitiligo monitored by non-invasive imaging during topical ruxolitinib treatment

  Francesca Feresin, Francesca Paola Sasso, Alberto Di Caro, Steven Paul Nisticò, Giovanni Pellacani, Annunziata Dattola, Maria Elisabetta Greco

  27-10-2026

  https://doi.org/10.4081/dr.2026.10964

  29

  PDF: 9

• A microRNA focus on acne

  Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross

  02-02-2024

  https://doi.org/10.4081/dr.2024.9902

  1165

  PDF: 751

  HTML: 75

• 23 | CURRENT CHALLENGES IN MODERATE ATOPIC DERMATITIS: AN ITALIAN DELPHI CONSENSUS I. Marzona¹, A. Costanzo², A. Campanati³, M. Esposito⁴, S. M. Ferrucci⁵, G. Girolomoni⁶, C. Patruno⁷, E. Pezzolo⁸, S. Ribero⁹, M. Rossi¹⁰, L. Stingeni¹¹, L. Politi¹, M. Napolitano¹² | ¹Helaglobe Srl; ²Dermatology Unit, IRCCS Humanitas Research Hospital Dermatology, Italy; ³Dermatological Clinic, Università Politecnica delle Marche, Italy; ⁴Biotechnological and Clinical Sciences University of L’Aquila, Italy; ⁵IRCCS Fondazione Ca’ Granda, Ospedale Maggiore Policlinico, Italy; ⁶Section of Dermatology, University of Verona, Italy; ⁷Medicine and Health Sciences, Molise University, Italy; ⁸Department of Dermatology, San Bortolo Hospital, Italy; ⁹Dermatology Clinic, University of Turin, Italy; ¹⁰Dermatology Unit, University of Brescia, Italy; ¹¹Dermatology Section, University of Perugia, Italy; ¹²Section of Dermatology, University of Naples, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11085

  100

  PDF: 118
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  https://doi.org/10.4081/dr.2023.9630

  1123

  PDF: 593

  HTML: 98